 |
市場調査レポート
商品コード
1448257
鼻腔カニューレの世界市場：市場規模、シェア、成長分析 - タイプ別、用途別、産業予測（2024～2031年）Global Nasal Cannula Market Size, Share, Growth Analysis, By Type(Low Flow and high flow), By Application(Hospitals, ambulatory health services) - Industry Forecast 2024-2031 |
||||||
| 鼻腔カニューレの世界市場：市場規模、シェア、成長分析 - タイプ別、用途別、産業予測（2024～2031年） |
|
出版日: 2024年03月06日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の鼻腔カニューレの市場規模は、2022年に72億4,000万米ドル、2023年に76億5,000万米ドルに達し、2024～2031年の予測期間中にCAGR 6.4％で成長し、2031年には118億2,000万米ドルに達すると予測されています。
近年、鼻腔カニューレの世界市場は顕著な成長と進歩を遂げています。広く利用されている医療機器である経鼻腔カニューレは、呼吸困難や呼吸補助が必要な患者に補助酸素を供給する上で重要な役割を果たしています。市場の勢いは、慢性閉塞性肺疾患（COPD）、喘息、睡眠時無呼吸症候群のような呼吸器疾患の有病率の上昇を含む様々な要因によって推進されています。さらに、人口の高齢化、ヘルスケア支出の増大、在宅ヘルスケアサービスの需要急増が、市場拡大のさらなる原動力となっています。
絶え間ない技術進歩の結果、快適性の向上、優れた酸素供給効率、患者のアドヒアランス向上を誇る革新的な鼻腔カニューレが登場しました。さらに、COVID-19パンデミックの発生は、特に呼吸器合併症と闘う患者の間で、鼻腔カニューレへの要求を増幅させています。
市場情勢は、先駆的な製品を導入し競争力を維持するために研究開発に積極的に取り組んでいる数多くの主要企業の存在によって特徴付けられています。北米は、呼吸器疾患の有病率の高さと有利な償還政策により、世界の鼻腔カニューレ市場を伝統的に支配してきたが、アジア太平洋は予測期間中に大きく成長する見込みです。この成長は、ヘルスケアインフラの拡大、呼吸器疾患に関する意識の高まり、ヘルスケアサービスへのアクセス強化によって促進されます。
まとめると、世界の鼻腔カニューレ市場は、技術の進歩、呼吸器疾患の増加、効果的な呼吸ケアソリューションに対する需要の高まりによって、当面、上昇基調を維持すると予測されます。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリ・プライマリデータソース
- 市場規模の推定
- 市場の前提条件・制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界の鼻腔カニューレ市場：タイプ別
- 市場概要
- 低流量・高流量
世界の鼻腔カニューレ市場：用途別
- 市場概要
- 病院
- 外来ヘルスケアサービス
- 長期ケアセンター
世界の鼻腔カニューレ市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Allied Healthcare Products, Inc.（US）
- Teleflex Incorporated（US）
- Flexicare Medical Ltd.（UK）
- Vapotherm Inc.（US）
- ResMed Inc.（US）
- Fairmont Medical（Australia）
- Fisher & Paykel Healthcare Limited（New Zealand）
- Well Lead Medical Co. Ltd.（China）
- Salter Labs（US）
- Hamilton Medical AG（Switzerland）
- Drive DeVilbiss Healthcare（US）
- Vygon（France）
- Besmed Health Business Corp.（Taiwan）
- Smiths Medical（UK）
- Great Group Medical Co. Ltd.（Taiwan）
- MAQUET Holding B.V. & Co. KG（Germany）
- Flexicare Medical（US）
- Progetti S.r.l.（Italy）
- Pulmodyne（US）
- GALEMed Corporation（Taiwan）
Global Nasal Cannula Market size was valued at USD 7.24 billion in 2022 and is poised to grow from USD 7.65 billion in 2023 to USD 11.82 billion by 2031, growing at a CAGR of 6.4% during the forecast period (2024-2031).
In recent years, the global market for nasal cannulas has experienced notable growth and advancements. Nasal cannulas, widely utilized medical devices, play a crucial role in delivering supplemental oxygen to patients encountering respiratory difficulties or necessitating respiratory support. The market's momentum is propelled by various factors, including the escalating prevalence of respiratory ailments like chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. Moreover, an aging population, augmented healthcare spending, and the surging demand for home healthcare services further fuel market expansion.
Continuous technological progress has resulted in the emergence of innovative nasal cannulas boasting enhanced comfort, superior oxygen delivery efficiency, and improved patient adherence. Furthermore, the onset of the COVID-19 pandemic has amplified the requirement for nasal cannulas, particularly among patients grappling with respiratory complications.
The market landscape is characterized by the presence of numerous key players actively involved in research and development initiatives to introduce pioneering products and maintain a competitive stance. While North America has traditionally dominated the global nasal cannula market, owing to its high prevalence of respiratory ailments and favorable reimbursement policies, the Asia Pacific region is poised for significant growth in the forecast period. This growth is fueled by the expanding healthcare infrastructure, heightened awareness regarding respiratory diseases, and enhanced access to healthcare services.
In summary, the global nasal cannula market is anticipated to sustain its upward trajectory in the foreseeable future, driven by advancements in technology, escalating respiratory disorders, and the escalating demand for effective respiratory care solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nasal Cannula Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Nasal Cannula Market Segmental Analysis
There are three segments in the global nasal cannula market: type, application, and geography. The market can be divided into Low Flow and High Flow segments based on type. The market is divided into segments according to application, including long-term care facilities, hospitals, and ambulatory health services. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.
Drivers of the Global Nasal Cannula Market
The rising incidence of respiratory illnesses is one of the major factors propelling the worldwide nasal cannula market. The need for respiratory support and oxygen therapy is increasing due to the increased prevalence of diseases like chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea worldwide. This is propelling the expansion of the nasal cannula market.
Restraints in the Global Nasal Cannula Market
The existence of substitute respiratory support equipment is a major commercial barrier. Although nasal cannulas are a common and useful tool, there are more sophisticated respiratory support alternatives available with mechanical ventilators and non-invasive ventilation (NIV) devices. Depending on how severe their respiratory disease is, certain patients might need these other devices, which in some circumstances could limit the nasal cannula market's potential for growth.
Market Trends of the Global Nasal Cannula Market
The growing use of high-flow nasal cannulas is a significant industry trend in the nasal cannula market globally. Patients with severe respiratory disorders can benefit from enhanced oxygenation and respiratory support thanks to high-flow nasal cannulas, which give a much higher flow rate of oxygen. The increased awareness of the advantages provided by high-flow nasal cannulas-such as increased patient comfort, less respiratory effort, and enhanced inspired air humidification-is what is causing this trend. The market for nasal cannulas is growing generally because more and more high-flow nasal cannulas are being used in different healthcare settings, such as emergency rooms, intensive care units, and hospitals.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Nasal Cannula Market by Type
- Market Overview
- Low Flow and high flow
Global Nasal Cannula Market by Application
- Market Overview
- Hospitals
- ambulatory health services
- long term care centres and others
Global Nasal Cannula Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Allied Healthcare Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Flexicare Medical Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vapotherm Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ResMed Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fairmont Medical (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fisher & Paykel Healthcare Limited (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Well Lead Medical Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Salter Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hamilton Medical AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Drive DeVilbiss Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vygon (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Besmed Health Business Corp. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smiths Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Great Group Medical Co. Ltd. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MAQUET Holding B.V. & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Flexicare Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Progetti S.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pulmodyne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GALEMed Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
